$AEYE

AudioEye, Inc. Hits New 52-Week Low at $5.55 Amidst Major Decline

AudioEye, Inc. has reached a new 52-week low of $5.55 on March 10, 2026, marking a substantial 70.98% decline in its stock price over the past year. The microcap company with an $84 million market cap is confronting significant financial challenges, including losses and a reliance on debt financing, despite a recent high in quarterly net sales. This performance highlights the stock's considerable volatility and scrutiny from institutional investors.

Original reporting
Published Mar 17, 2026, 7:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 17, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AudioEye, Inc. Hits New 52-Week Low at $5.55 Amidst Major Decline — source image
Decision brief

The 30-second read

$AEYEBearishLow
01

Why it matters

The stock's decline reflects investor concerns over financial stability, which could lead to further downside or a potential recovery if the company improves its financial health.

02

Market read

The news is highly relevant for traders focusing on microcap stocks and technology sector movements.

03

What to watch

Potential for short-term volatility due to market speculation; broader industry trends could influence stock performance.

Timing: short-term

Background

AudioEye, Inc. specializes in digital accessibility solutions. The company has faced financial difficulties, leading to a sharp stock decline.

Company-level read

Ticker impact

$AEYEBearishMedium confidence
Context

High relevance due to significant stock decline and bearish sentiment.

Expected impact

Possible continued decline in the near term, with a potential support level around $5.00. Long-term outlook remains uncertain due to financial instability.

Evidence & confidence

The significant decline and negative sentiment support a cautious outlook. However, recent sales figures and market volatility introduce uncertainty.

Market effects

The decline may negatively impact the technology and financial markets sectors, especially microcap stocks.

Limited regional impact; primarily affects US-based microcap stocks.

Minimal global relevance due to company size and sector.

Counterpoint

The recent high in quarterly sales may indicate a potential turnaround; the stock could rebound if financial challenges are addressed.

Key entities

  • AudioEye, Inc.

    A provider of digital accessibility solutions.

Related articles

$AEYEMed

AudioEye (AEYE) Q2 2026 Earnings Call Transcript

AudioEye reported Q2 2026 revenue of $10.7M, up 9% YoY, with adjusted EBITDA of $3M, a 54% increase. ARR reached $42.3M, up 11% sequentially. The company raised full-year adjusted EBITDA guidance to at least $12.7M and adjusted EPS to at least $0.98. Management highlighted growth in enterprise ARR and partner revenue, while noting risks from AI-driven accessibility issues and shifting legal risks to interior web pages.

$AEYEMed

Audioeye Q2 Earnings Call Highlights

AudioEye (NASDAQ:AEYE) reported Q2 net loss of $900,000, or $0.07/share, versus breakeven a year earlier, when a $1.4 million contingent consideration revaluation boosted results. Adjusted free cash flow was $2.6 million. Full-year adjusted EBITDA guidance rose to at least $12.7 million; revenue midpoint held at $43.5-$44.0 million. Q3 revenue forecast: $10.85-$11.05 million.

$AEYEHighAI 9/10

AudioEye Reports Record Second Quarter 2026 Results

AudioEye (Nasdaq: AEYE) reported Q2 2026 results for the quarter ended June 30, 2026. ARR rose to $42.3M from $41.2M sequentially and 11% YoY. Revenue increased 9% to $10.7M. Adjusted EBITDA was $3.0M. The company raised full-year adjusted EBITDA guidance and expects Q3 revenue $10.85M-$11.05M.

$AEYEMed

AUDIOEYE INC (AEYE): Results of Operations and Financial Condition

AUDIOEYE INC (AEYE) filed an SEC Form 8-K — Results of Operations and Financial Condition. ​ ​ Exhibit 99.1 ​ AudioEye Reports Record Second Quarter 2026 Results Forty-Second Consecutive Period of Record Revenue TUCSON, Ariz. — August 13, 2026 — AudioEye, Inc. (Nasdaq: AEYE) (“AudioEye” or the “Company”) , an industry-leading digital accessibility company, reported fin

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.